Stress Hormones Disrupt Internal Maps and Mental Focus
New studies from MIT and Ruhr University Bochum show how stress hormones like cortisol disrupt grid cells and the brain's ability to focus in noisy rooms.
Health
Showing 145-156 of 204 articles
Vitamin B2 Discoveries Reveal New Cancer Weakness
W? rzburg researchers have identified a biological paradox involving one of the most common dietary supplements in the Western world.
Grail CEO Bob Ragusa Resigns After Clinical Trial Setback
Bob Ragusa vacated his post as chief executive of Grail late Thursday night, following a series of clinical trial results that failed to meet.
FDA Committee Selects Viral Strains for 2026 Flu Shots
FDA advisers selected a trivalent formula for the 2026-2027 flu vaccine season.
Viral Infections and Polyps Drive New Cancer Risk Warnings
New cancer-risk warnings link severe respiratory infections with lung inflammation and highlight higher bowel-cancer risk in patients with mixed polyps.
Voters Credit Trump for Lower Drug Prices as White House Pauses Vaccine Push
Voters are giving the Trump administration credit for possible prescription drug price relief.
Medicaid Expansion Targets Health Gaps Before Prison Release
A Medicaid policy shift aims to improve care before prison release, reducing gaps in medication, mental health and addiction treatment.
Falling Suitcase Reveals Terminal Brain Cancer in London Woman
A falling suitcase injury led doctors to discover terminal brain cancer in a London woman.
Aging Population Rejects Smart Home Technology
Older consumers are rejecting smart home features when they make basic appliances harder to use.
Doctors Turn to Virtual Reality to Combat Rising Hospital Violence
Doctors turned to virtual reality to prepare staff for hospital violence and improve patient-facing crisis response.
Medical Researchers Predict Sharp Decline in Cancer Mortality Rates
Brazil’s lung cancer burden shows how late diagnosis drives mortality and public costs.
Advisers Seek to Curb $76 Billion Medicare Advantage Surplus
Congressional advisers report a $76 billion surplus for Medicare Advantage insurers as costs rise 14 percent above traditional Medicare spending levels.